Published Date：Mar.2021
Industry：Pharma & Healthcare
Pages：104 Table Number：126
Single User Price：￥3650.00
Enterprise User Price：￥5600.00
Summary As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%. Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly optimistic. The resumption of work and production not only brought economic data back, but also triggered a rebound in the epidemic situation. At present, the United States is still the 'epicenter' of the global epidemic. The total number of confirmed cases has exceeded 4.8 million, and the epidemic situation in some European countries has also rebounded. Affected by this, more than 20 states in the United States have announced the suspension or withdrawal of part of the economic restart plan. Britain and Italy have also decided to extend the state of emergency. The rebound of the epidemic situation has posed considerable risks to the economic prospects of Europe and the United States. In the second quarter of this year, US GDP shrank by 9.5% on a month on month basis, or 32.9% at an annual rate, the largest decline since the 1940s. Data show that the sharp decline in personal consumption is the main drag on the U.S. GDP growth in the second quarter. Compared with the United States, Europe's economic contraction in the second quarter was smaller, but it was also the lowest on record, with Germany and France contracting more than 10%. According to the data released by the Federal Bureau of statistics, Germany's GDP fell by 10.1% in the second quarter after adjusting for prices, seasons and working days, the largest decline since the quarterly economic data were available in 1970. Thanks to the effective control and policy support of the new epidemic, China's economy rebounded sharply in the second quarter. The growth rate of manufacturing industry, which accounted for about 28% of GDP, rebounded sharply to 4.4% from the negative value in the first quarter. Chinese original equipment manufacturers (OEMs) and suppliers are ramping up production. And there are increased investments in digital footprints in manufacturing. OEMs in other parts of the world are offering incentives to drive sales. XYZResearch published a report for global TNF Inhibitors market in this environment. In terms of revenue, this research report indicated that the global TNF Inhibitors market was valued at USD XXX million in 2020, and it is expected to reach a value of USD XXX million by 2027, at a CAGR of XX % over the forecast period 2021-2027. Correspondingly, the forecast analysis of TNF Inhibitors industry comprises of China, USA, Japan, India, Korea and South America, with the production and revenue data in each of the sub-segments. The AbbVie aims at producing XX K Units TNF Inhibitors in 2020, with XX % production to take place in global market, Amgen accounts for a volume share of XX %. Regional Segmentation (Value; Revenue, USD Million, 2026-2027) of TNF Inhibitors Market by XYZResearch Include China EU USA Japan India Southeast Asia South America Competitive Analysis; Who are the Major Players in TNF Inhibitors Market? AbbVie Amgen Johnson & Johnson Novartis Pfizer UCB ... Major Type of TNF Inhibitors Covered in XYZResearch report: TNF inhibitors for RA TNF inhibitors for psoriasis TNF inhibitors for IBD Others Application Segments Covered in XYZResearch Market Hospital Pharmacies Specialty Pharmacies Online Pharmacies For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents Global TNF Inhibitors Market Analysis 2021, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate 1 Market Scope 1.1 Product Details and Introduction 1.1.1 TNF inhibitors for RA -Product Introduction and Major Manufacturers 1.1.2 TNF inhibitors for psoriasis -Product Introduction and Major Manufacturers 1.1.3 TNF inhibitors for IBD -Product Introduction and Major Manufacturers 1.1.4 Others -Product Introduction and Major Manufacturers 1.2 Market Snapshot 1.2.1 Major Companies Overview 1.2.2 Market Concentration 1.2.3 Six-Year Compound Annual Growth Rate (CAGR) 2 Global TNF Inhibitors Market Assessment, by Segmentation 2.1 Type Breakdown Estimates & Forecast, Sales Volume (2026-2027) 2.2 Type Breakdown Estimates & Forecast, Sales Value (2026-2027) 2.3 Application Breakdown Estimates & Forecast, by Application (2026-2027) 3 Regional Market Analysis 3.1 China TNF Inhibitors Market 3.1.1 Top Companies leading TNF Inhibitors Development in China (2016-2021) 3.1.2 Sales Value of Major Company in China Market (2016-2021) 3.1.3 China TNF Inhibitors Price (USD/Unit), by Type (2019-2020) 3.1.4 Sales in China Market, by Type (2026-2027) 3.2 EU TNF Inhibitors Market 3.2.1 Top Companies leading TNF Inhibitors Development in EU (2016-2021) 3.2.2 Sales Value of Major Company in EU Market (2016-2021) 3.2.3 EU TNF Inhibitors Price (USD/Unit), by Type (2019-2020) 3.2.4 Sales in EU Market, by Type (2026-2027) 3.3 USA TNF Inhibitors Market 3.3.1 Top Companies leading TNF Inhibitors Development in USA (2016-2021) 3.3.2 Sales Value of Major Company in USA Market (2016-2021) 3.3.3 USA TNF Inhibitors Price (USD/Unit), by Type (2019-2020) 3.3.4 Sales in USA Market, by Type (2026-2027) 3.4 Japan TNF Inhibitors Market 3.4.1 Top Companies leading TNF Inhibitors Development in Japan (2016-2021) 3.4.2 Sales Value of Major Company in Japan Market (2016-2021) 3.4.3 Japan TNF Inhibitors Price (USD/Unit), by Type (2019-2020) 3.4.4 Sales in Japan Market, by Type (2026-2027) 3.5 India TNF Inhibitors Market 3.5.1 Top Companies leading TNF Inhibitors Development in India (2016-2021) 3.5.2 Sales Value of Major Company in India Market (2016-2021) 3.5.3 India TNF Inhibitors Price (USD/Unit), by Type (2019-2020) 3.5.4 Sales in India Market, by Type (2026-2027) 3.6 Southeast Asia TNF Inhibitors Market 3.6.1 Top Companies leading TNF Inhibitors Development in Southeast Asia (2016-2021) 3.6.2 Sales Value of Major Company in Southeast Asia Market (2016-2021) 3.6.3 Southeast Asia TNF Inhibitors Price (USD/Unit), by Type (2019-2020) 3.6.4 Sales in Southeast Asia Market, by Type (2026-2027) 3.7 South America TNF Inhibitors Market 3.7.1 Top Companies leading TNF Inhibitors Development in South America (2016-2021) 3.7.2 Sales Value of Major Company in South America Market (2016-2021) 3.7.3 South America TNF Inhibitors Price (USD/Unit), by Type (2019-2020) 3.7.4 Sales in South America Market, by Type (2026-2027) 4 Value Chain (Impact of COVID-19) 4.1 TNF Inhibitors Value Chain Analysis 4.1.1 Upstream 4.1.2 Downstream 4.2 COVID-19 Impact on TNF Inhibitors Industry 4.2.1 Industrial Policy Issued Under the Epidemic Situation 4.3 Cost-Under the Epidemic Situation 4.3.1 Cost of Raw Material 4.4 Channel Analysis 4.4.1 Distribution Channel-Under the Epidemic Situation 4.4.2 Distributors 5 Regional Market Forecast (2021-2027) 5.1 Global TNF Inhibitors Sales and Growth Rate (2021-2027) 5.2 Global TNF Inhibitors Sales Value and Growth Rate (2021-2027) 6 TNF Inhibitors Competitive Analysis 6.1 AbbVie 6.1.1 AbbVie Company Profiles 6.1.2 AbbVie Product Introduction 6.1.3 AbbVie TNF Inhibitors Production, Revenue (2016-2021) 6.1.4 SWOT Analysis 6.2 Amgen 6.2.1 Amgen Company Profiles 6.2.2 Amgen Product Introduction 6.2.3 Amgen TNF Inhibitors Production, Revenue (2016-2021) 6.2.4 SWOT Analysis 6.3 Johnson & Johnson 6.3.1 Johnson & Johnson Company Profiles 6.3.2 Johnson & Johnson Product Introduction 6.3.3 Johnson & Johnson TNF Inhibitors Production, Revenue (2016-2021) 6.3.4 SWOT Analysis 6.4 Novartis 6.4.1 Novartis Company Profiles 6.4.2 Novartis Product Introduction 6.4.3 Novartis TNF Inhibitors Production, Revenue (2016-2021) 6.4.4 SWOT Analysis 6.5 Pfizer 6.5.1 Pfizer Company Profiles 6.5.2 Pfizer Product Introduction 6.5.3 Pfizer TNF Inhibitors Production, Revenue (2016-2021) 6.5.4 SWOT Analysis 6.6 UCB 6.6.1 UCB Company Profiles 6.6.2 UCB Product Introduction 6.6.3 UCB TNF Inhibitors Production, Revenue (2016-2021) 6.6.4 SWOT Analysis 7 Conclusion
List of Tables and Figures Figure Product Introduction Table Production (K Units) and Revenue (Million USD) of Major Players (2016-2021) Figure Global TNF Inhibitors Production Market Share of Top 5 Players Table CAGR of Major Market (2021-2027) Table CAGR in Terms of Production of Each Type (2026-2027) Table CAGR in Terms of Production of Each Application (2026-2027) Table Global TNF Inhibitors Sales (K Unit) by Type (2026-2027) Figure Global TNF Inhibitors Sales (K Unit) and Growth Rate (2026-2027) Figure Global TNF Inhibitors Sales Market Share (%) by Type (2019 -2020) Table Global TNF Inhibitors Sales Value (Million USD) by Type (2026-2027) Figure Global TNF Inhibitors Sales Value (Million USD) and Growth Rate (2026-2027) Figure Global TNF Inhibitors Sales Value Market Share (%) by Type (2019-2020) Table Global TNF Inhibitors Sales (K Unit) by Application (2026-2027) Table China TNF Inhibitors Sales (K Unit) of Major Company (2016-2021) Table China TNF Inhibitors Sales Market Share of Major Company (2016-2021) Table China TNF Inhibitors Sales Value (Million USD) of Major Company (2016-2021) Figure China TNF Inhibitors Sales Value (Million USD) and Growth Rate (2016-2021) Table China TNF Inhibitors Sales Value Share of Major Company (2016-2021) Table China TNF Inhibitors Price (USD/Unit), by Type (2019-2020) Table China TNF Inhibitors Sales (Unit) by Type (2026-2027) Figure China TNF Inhibitors Sales (Unit) by Type (2026-2027) Table EU TNF Inhibitors Sales (K Unit) of Major Company (2016-2021) Table EU TNF Inhibitors Sales Market Share of Major Company (2016-2021) Table EU TNF Inhibitors Sales Value (Million USD) of Major Company (2016-2021) Figure EU TNF Inhibitors Sales Value (Million USD) and Growth Rate (2016-2021) Table EU TNF Inhibitors Sales Value Share of Major Company (2016-2021) Table EU TNF Inhibitors Price (USD/Unit), by Type (2019-2020) Table EU TNF Inhibitors Sales (Unit) by Type (2026-2027) Figure EU TNF Inhibitors Sales (Unit) by Type (2026-2027) Table USA TNF Inhibitors Sales (K Unit) of Major Company (2016-2021) Table USA TNF Inhibitors Sales Market Share of Major Company (2016-2021) Table USA TNF Inhibitors Sales Value (Million USD) of Major Company (2016-2021) Figure USA TNF Inhibitors Sales Value (Million USD) and Growth Rate (2016-2021) Table USA TNF Inhibitors Sales Value Share of Major Company (2016-2021) Table USA TNF Inhibitors Price (USD/Unit), by Type (2019-2020) Table USA TNF Inhibitors Sales (Unit) by Type (2026-2027) Figure USA TNF Inhibitors Sales (Unit) by Type (2026-2027) Table Japan TNF Inhibitors Sales (K Unit) of Major Company (2016-2021) Table Japan TNF Inhibitors Sales Market Share of Major Company (2016-2021) Table Japan TNF Inhibitors Sales Value (Million USD) of Major Company (2016-2021) Figure Japan TNF Inhibitors Sales Value (Million USD) and Growth Rate (2016-2021) Table Japan TNF Inhibitors Sales Value Share of Major Company (2016-2021) Table Japan TNF Inhibitors Price (USD/Unit), by Type (2019-2020) Table Japan TNF Inhibitors Sales (Unit) by Type (2026-2027) Figure Japan TNF Inhibitors Sales (Unit) by Type (2026-2027) Table India TNF Inhibitors Sales (K Unit) of Major Company (2016-2021) Table India TNF Inhibitors Sales Market Share of Major Company (2016-2021) Table India TNF Inhibitors Sales Value (Million USD) of Major Company (2016-2021) Figure India TNF Inhibitors Sales Value (Million USD) and Growth Rate (2016-2021) Table India TNF Inhibitors Sales Value Share of Major Company (2016-2021) Table India TNF Inhibitors Price (USD/Unit), by Type (2019-2020) Table India TNF Inhibitors Sales (Unit) by Type (2026-2027) Figure India TNF Inhibitors Sales (Unit) by Type (2026-2027) Table Southeast Asia TNF Inhibitors Sales (K Unit) of Major Company (2016-2021) Table Southeast Asia TNF Inhibitors Sales Market Share of Major Company (2016-2021) Table Southeast Asia TNF Inhibitors Sales Value (Million USD) of Major Company (2016-2021) Figure Southeast Asia TNF Inhibitors Sales Value (Million USD) and Growth Rate (2016-2021) Table Southeast Asia TNF Inhibitors Sales Value Share of Major Company (2016-2021) Table Southeast Asia TNF Inhibitors Price (USD/Unit), by Type (2019-2020) Table Southeast Asia TNF Inhibitors Sales (Unit) by Type (2026-2027) Figure Southeast Asia TNF Inhibitors Sales (Unit) by Type (2026-2027) Table South America TNF Inhibitors Sales (K Unit) of Major Company (2016-2021) Table South America TNF Inhibitors Sales Market Share of Major Company (2016-2021) Table South America TNF Inhibitors Sales Value (Million USD) of Major Company (2016-2021) Figure South America TNF Inhibitors Sales Value (Million USD) and Growth Rate (2016-2021) Table South America TNF Inhibitors Sales Value Share of Major Company (2016-2021) Table South America TNF Inhibitors Price (USD/Unit), by Type (2019-2020) Table South America TNF Inhibitors Sales (Unit) by Type (2026-2027) Figure South America TNF Inhibitors Sales (Unit) by Type (2026-2027) Figure Value Chain Structure of TNF Inhibitors Table Value Chain Table Key Suppliers of Raw Material/Components Table Key Downstream Customer in Each Application Field Table Industry News List of TNF Inhibitors Figure Cost Structure of TNF Inhibitors in 2020 Table Distributors/Traders List Table Regional Market Sales (K Unit) (2021-2027) Table Regional Market Sales Share (2021-2027) Figure Global TNF Inhibitors Sales (Unit), Growth Rate & Market Share (2021-2027) Table Regional Market Sales Value (Million USD) (2021-2027) Table Regional Market Sales Value Share (2021-2027) Figure Global TNF Inhibitors Sales Value (Million USD), Growth Rate & Market Share (2021-2027) Table AbbVie Profiles Table AbbVie TNF Inhibitors Product Introduction Table AbbVie TNF Inhibitors Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure AbbVie SWOT Analysis Table Amgen Profiles Table Amgen TNF Inhibitors Product Introduction Table Amgen TNF Inhibitors Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Amgen SWOT Analysis Table Johnson & Johnson Profiles Table Johnson & Johnson TNF Inhibitors Product Introduction Table Johnson & Johnson TNF Inhibitors Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Johnson & Johnson SWOT Analysis Table Novartis Profiles Table Novartis TNF Inhibitors Product Introduction Table Novartis TNF Inhibitors Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Novartis SWOT Analysis Table Pfizer Profiles Table Pfizer TNF Inhibitors Product Introduction Table Pfizer TNF Inhibitors Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Pfizer SWOT Analysis Table UCB Profiles Table UCB TNF Inhibitors Product Introduction Table UCB TNF Inhibitors Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021)
